Press Enter to search · Esc to close
A new clinical review argues that dentists routinely see the earliest orofacial clues to Parkinson's, Alzheimer's, ALS and MS — and that catching them could shave months off the diagnostic odyssey.
Two new GeroScience studies suggest that low-cost scalp recordings — paired with machine learning — can flag amnestic MCI and stage Parkinson's with startling accuracy. The catch: it's early.
A provocative review of brain tissue from young Mexico City residents argues that ultrafine air pollution may seed neurodegeneration decades before symptoms appear. The evidence is moderate — but hard to unsee.
A phase 3 Parkinson's trial, a kidney meta-analysis, an ocular cohort and new mechanistic work suggest the GLP-1 class is becoming a multi-system intervention — with important caveats.